Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The Australia Digital Pathology Market was valued at $28.9 Million in 2026 and projected to reach to $51 Million by 2031, representing a compound annual growth rate of 12.1%. Australia's digital pathology market is poised for sustained growth through 2031, driven by increasing healthcare digitalization and the adoption of advanced diagnostic technologies across major medical institutions.

Australia Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Digital Pathology Market Trends and Insights

  • This expansion reflects Australia's increasing adoption of advanced diagnostic technologies and healthcare digitalization initiatives.
  • Australia is positioning itself as a key market within the Asia Pacific region, driven by rising demand for efficient pathology workflows and improved diagnostic accuracy. The Australian digital pathology sector benefits from strong healthcare infrastructure, regulatory support, and growing investment in laboratory automation.
  • Australia's pathology providers are increasingly integrating digital solutions to enhance operational efficiency and enable remote consultation capabilities.
  • Between 2026 and 2031, Australia is expected to see accelerated adoption across both public and private healthcare institutions, supported by favorable reimbursement policies and technological advancement. Australia's market trajectory reflects broader regional trends while maintaining distinct characteristics shaped by local healthcare priorities and investment patterns.
  • The 12.1% compound annual growth rate underscores Australia's commitment to modernizing its pathology infrastructure and improving patient outcomes through digital innovation..

Key Market Statistics

  • CAGR (2026-2031) 12.1% CAGR
  • Market Size, 2026 ~USD 28.9 Million
  • Forecast, 2031 ~USD 51 Million
  • Country Australia

Australia Digital Pathology Market Overview

Market Valuation Growth :

Australia's digital pathology market is valued at $28.9 million in 2026 and is projected to reach $51.0 million by 2031, representing a robust 12.1% CAGR over the forecast period.

Healthcare Digitalization Drive :

Australian healthcare institutions are increasingly adopting advanced diagnostic technologies as part of broader digitalization initiatives, positioning the country as a key growth market within the Asia Pacific region.

Efficiency and Diagnostic Advancement :

Rising demand for efficient pathology solutions is driving market expansion, with Australian laboratories and hospitals seeking to improve diagnostic accuracy, reduce turnaround times, and enhance operational efficiency.

Regional Market Leadership :

Australia is establishing itself as a leading digital pathology adopter in Asia Pacific, supported by strong healthcare infrastructure, regulatory frameworks, and investment in medical technology innovation.

Australia Digital Pathology Market Dynamics

  • The market's 12.1% CAGR reflects strong demand from pathology laboratories seeking to modernize operations and improve diagnostic capabilities.
  • Government healthcare initiatives and private sector investments in medical technology are accelerating the transition from traditional to digital pathology workflows.
  • Australia's mature healthcare system and emphasis on clinical excellence create favorable conditions for digital pathology adoption.
  • The market is expected to benefit from growing awareness of the benefits of whole slide imaging, AI-assisted diagnostics, and remote consultation capabilities among Australian healthcare providers..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • Australia's digital pathology market is valued at $28.9 million in 2026 and is forecast to reach $51.0 million by 2031, representing a 12.1% CAGR.
          • Australia's strong healthcare infrastructure and regulatory environment are driving adoption of digital pathology solutions across public and private institutions.
          • Australia's pathology providers are leveraging digital technologies to improve diagnostic efficiency, enable remote consultations, and enhance patient outcomes.
          • Australia's market growth is supported by increasing investment in laboratory automation and healthcare digitalization initiatives through 2031.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          Australia Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024–2031

          Segment20242025202620272028202920302031CAGR (%)
          ACADEMIC & RESEARCH INSTITUTES2.172.392.642.923.243.64.024.4811.2
          CONTRACT RESEARCH ORGANIZATIONS2.452.723.043.393.84.264.795.3912.2
          DIAGNOSTIC & REFERENCE LABORATORIES5.536.176.917.758.719.811.0612.5112.6
          HOSPITALS & HEALTH SYSTEMS8.118.989.9611.0712.3313.7615.3917.2511.6
          OTHER END USERS0.370.410.440.470.510.550.580.616.9
          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES3.824.314.865.496.227.068.039.1513.5
          VETERINARY LABORATORIES0.860.931.021.11.21.321.441.589.2
          TOTAL23.3225.9228.8632.2136.0140.3545.3150.9812.1

          Target Audience

          • Digital Pathology Vendors : Vendors need Australia-specific market data to develop localized go-to-market strategies, understand competitive positioning, and identify growth opportunities in this high-potential Asia Pacific market.
          • Healthcare IT Investors : Investors require detailed market insights on Australia's digital pathology sector to evaluate investment opportunities, assess market maturity, and forecast returns in the healthcare technology space.
          • Hospital and Laboratory Administrators : Healthcare leaders need market intelligence to justify digital pathology investments, benchmark against industry trends, and plan technology adoption roadmaps aligned with market growth.
          • Medical Device Manufacturers : Manufacturers require Australia-specific demand forecasts and market dynamics to guide product development, regulatory strategy, and distribution partnerships in the region.
          • Healthcare Consultants and Analysts : Consultants need comprehensive Australia market data to support client advisory services, competitive analysis, and strategic recommendations for healthcare digitalization initiatives.

          Key Companies in the Australia Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          Reasons to Buy this Report

          • Market-Specific Growth Data : Access precise valuation figures and CAGR projections specific to Australia's digital pathology market, enabling accurate financial forecasting and investment planning for the region.
          • Competitive Landscape Intelligence : Understand Australia's unique market dynamics, key players, and competitive positioning within the Asia Pacific region to inform market entry strategies and partnership opportunities.
          • Regulatory and Healthcare Context : Gain insights into Australia's healthcare infrastructure, regulatory environment, and digitalization initiatives that directly impact digital pathology adoption and implementation timelines.
          • Demand Driver Analysis : Identify specific factors driving Australian healthcare institutions' adoption of digital pathology, including efficiency improvements, diagnostic advancement, and operational cost reduction.
          • Strategic Investment Guidance : Make informed decisions on market expansion, product localization, and resource allocation in Australia based on comprehensive market sizing and growth trajectory analysis.

          Frequently asked questions

          What is the current size of Australia's digital pathology market?

          Australia's digital pathology market is valued at $28.9 million in 2026 and is expected to grow to $51.0 million by 2031.

          What is the growth rate of Australia's digital pathology market?

          Australia's digital pathology market is growing at a compound annual growth rate (CAGR) of 12.1% from 2026 to 2031.

          What factors are driving growth in Australia's digital pathology market?

          Australia's market growth is driven by strong healthcare infrastructure, regulatory support, increasing laboratory automation investments, and demand for improved diagnostic efficiency and remote consultation capabilities.

          Which healthcare institutions in Australia are adopting digital pathology solutions?

          Both public and private healthcare institutions across Australia are increasingly adopting digital pathology solutions to enhance operational efficiency and diagnostic accuracy.

          How does Australia's digital pathology market compare to the broader Asia Pacific region?

          Australia represents a key market within Asia Pacific, with a 12.1% CAGR reflecting strong local healthcare priorities and investment patterns that support digital pathology adoption.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status